Aquaporin-1 and Sodium-Hydrogen Exchangers as Pharmacological Targets in Diabetic Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|4|361-365

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.4, 2015-04, pp. : 361-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of sodium channel and sodium/hydrogen exchanger to sodium accumulation in the ischemic myocardium

By Tanonaka K.   Takasaki A.   Kajiwara H.   Takeo S.  

General Pharmacology, Vol. 34, Iss. 3, 2000-03 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite

Seizures and Sodium Hydrogen Exchangers: Potential of Sodium Hydrogen Exchanger Inhibitors as Novel Anticonvulsants

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 4, 2008-10 ,pp. : 343-347

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the myocardial sodium–hydrogen exchange for treatment of heart failure

By  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 291-298

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of sodium-hydrogen exchange as therapeutic agents for the treatment of heart disease

By Karmazyn Morris  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3212-3221

Bentham Science Publishers

Access to resources Recommend Favorite